P Rosen
Overview
Explore the profile of P Rosen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
392
Citations
2036
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wineski R, Beltran-Ale G, Simpson R, Evarts M, Stein J, Rosen P, et al.
Int J Pediatr Otorhinolaryngol
. 2023 Jul;
171:111657.
PMID: 37441989
Introduction: We previously reported that endoscopic repair of a Type 1 Laryngeal Cleft (LC1) or Deep Interarytenoid Groove (DIG) improves swallowing function postoperatively. However, caregivers often ask about the timeline...
2.
Wineski R, Panico E, Karas A, Rosen P, Van Diver B, Norwood T, et al.
Int J Pediatr Otorhinolaryngol
. 2021 Aug;
150:110874.
PMID: 34392101
Introduction: The best strategy to manage an interarytenoid defect [Type 1 laryngeal cleft (LC-1) or deep interarytenoid groove (DIG)] in pediatric aerodigestive patients with dysphagia remains uncertain. This study compared...
3.
Rosen P, Rosen S, Ezban M, Persson E
J Thromb Haemost
. 2016 May;
14(7):1420-7.
PMID: 27169618
Unlabelled: Essentials Nonacog beta pegol (N9-GP) activity is overestimated in clot method using silica-based reagents. Mimicking contact activation phase with silica reveals N9-GP activation before recalcification. Localization of N9-GP to...
4.
Dragovich T, Laheru D, Dayyani F, Bolejack V, Smith L, Seng J, et al.
Cancer Chemother Pharmacol
. 2014 Jun;
74(2):379-87.
PMID: 24939212
Purpose: Vatalanib (PTK 787/ZK22584) is an oral poly-tyrosine kinase inhibitor with strong affinity for platelet-derived growth factor and vascular endothelial growth factor (VEGF) receptors. We conducted an open-label, phase II...
5.
Rosen P, Popescu V, Hayward K, Wyman C
IEEE Comput Graph Appl
. 2014 May;
31(6):68-83.
PMID: 24808260
No abstract available.
6.
Tschope D, Rosen P, Schwippert B, Kehrel B, Schauseil S, Esser J, et al.
Platelets
. 2010 Nov;
1(3):127-33.
PMID: 21043968
'Ex vivo' testing of functional platelet properties using conventional techniques reflects the overall behaviour of the whole platelet population in the sample under investigation. Since many functional aspects depend on...
7.
Rosen P, Schwippert B, Kaufmann L, Tschope D
Platelets
. 2010 Nov;
5(1):45-52.
PMID: 21043743
Adhesion molecules such as P-selectin (CD 62), glycoprotein (CP) 53 (CD63) and thrombospondin play a decisive role in the thrombogenic transformation of platelets. Here we present evidence obtained using flow...
8.
Berris B, Rother I, Rosen P
Can Med Assoc J
. 2010 Mar;
97(4):191.
PMID: 20328991
No abstract available.
9.
Ebel D, Toma O, Appler S, Baumann K, Frassdorf J, Preckel B, et al.
Horm Metab Res
. 2008 Sep;
41(1):10-5.
PMID: 18810710
Diabetes mellitus blocks protection by ischemic preconditioning (IPC), but the mechanism is not known. We investigated the effect of ischemic preconditioning on mitogen-activated protein kinases (extracellular signal-regulated kinases 1 and...
10.
Ban K, Sanchez L, Bramwell K, Sakles J, Davis D, Wolfe R, et al.
Intern Emerg Med
. 2007 Nov;
2(3):219-23.
PMID: 17987275
No abstract available.